Jayne Shaw, Co-Founder and Executive Chair of BCAL Diagnostics, a biotechnology company focused on improving breast cancer screening and diagnostics, shares BCAL’s mission to provide early and accurate diagnoses, enabling timely intervention and better health outcomes for women. With a commitment to advancing breast cancer detection technology, BCAL Diagnostics is playing a vital role in empowering women and improving the effectiveness of cancer care.
